MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s13205-026-04926-5

Медицинская библиотека · 3 Biotech · 2026

Magnolol confers neurotrophic effects against MPTP/p-induced Parkinson's disease in mice via anti-inflammatory, anti-apoptotic mechanisms and PI3K/AKT/GSK3β/MAPK/mTOR signalling regulation.

Grigore Georgiana, Molesworth Mike, Vontea Andreea, Basnawi Abdullah Hasan, Celep Ogeday, Jesudoss Sylvian Patrick

СтатьяПеревод пока не подготовлен

Аннотация

The current hypothesis investigated the neurotrophic effect of magnolol (ML) against MPTP/p-induced neurotoxicity in Parkinson's disease (PD) mice, focusing on the molecular mechanisms of PI3K/Akt/GSK3β and MAPK signalling pathways. To determine the effective dose, 6 mice/group were employed for the dose-dependent study and brain-protective study. Behavioural deficits (open field test, narrow beam walking), dopamine (DA) depletion, lipid peroxidation, antioxidant levels, histology (H&E, PAS, and MT), inflammatory cytokines, DAT and VMAT2 expressions, SN region expressions of BDNF, GDNF, VEGF, and TrkB, RT-PCR of p38, MAPK, ERK, and JNK, and GSK3β/mTOR/PI3K/Akt signalling protein marker expression were evaluated. After 5 weeks of ML therapy, motor impairment significantly decreased, and lipid peroxidation, antioxidant levels, and inflammatory cytokines were restored. ML increased tropomyosin receptor kinase B (TrkB) expression, dopamine insufficiency, and MPTP/p-induced neurotrophic factors. ML therapy significantly decreased mRNA activation associated with MAPK/p38/JNK. Furthermore, ML increased PI3K, Akt, GSK3β, and mTOR phosphorylation, suggesting ML controlled the PI3K/Akt/mTOR signalling pathway. Altogether, this study offers a more thorough examination of the brain-protective effect of ML on dopaminergic neurons when combined with chronic PD. Additionally, it brings up the possibility of using ML as a new preventive and therapeutic drug. Study limitations include use of an acute MPTP/p model rather than progressive PD, absence of pharmacokinetic data, and no pathway confirmation using inhibitors. Long-term efficacy and clinical translation require further investigation.

Для цитирования: Grigore Georgiana, Molesworth Mike, Vontea Andreea, Basnawi Abdullah Hasan, Celep Ogeday, Jesudoss Sylvian Patrick. Magnolol confers neurotrophic effects against MPTP/p-induced Parkinson's disease in mice via anti-inflammatory, anti-apoptotic mechanisms and PI3K/AKT/GSK3β/MAPK/mTOR signalling regulation.. 3 Biotech. 2026. DOI: 10.1007/s13205-026-04926-5.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.